|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Nordic Capital, a Swedish private equity firm. |
|---|---|
| Transferring Party | Atos Medical AB, a subsidiary of Fisher Scientific International Inc. (FSH), a manufacturers ear, nose, and throat medical devices. |
| Sector | Medical Devices |
| Date | March 8, 2005 |
| Analysis Atos had approximately $38 million in revenues for 2004. Deal value about $110 million. Nordic expects Atos to grow more as an autonomous unit, having been acquired by Fisher as part of its 2003 Perbio Science acquisition. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |